US Stock MarketDetailed Quotes

EBS Emergent BioSolutions

Watchlist
  • 4.660
  • -0.260-5.28%
Close Mar 28 16:00 ET
  • 4.620
  • -0.040-0.86%
Post 20:01 ET
253.21MMarket Cap-1.29P/E (TTM)

Emergent BioSolutions Key Stats

Emergent BioSolutions Q4 2024 Earnings Date

Currency:USDMar 3, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
254.67M
194.70M
-59.97M
Miss Est.
-7.93%
-29.61%
-23.55%
EPS
-0.25
-0.58
-0.33
Miss Est.
+73.73%
+38.95%
-132.46%
Buy

Feb 28, 2025

Emergent BioSolutions Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 194.000M--
--2025/Q1-- / 218.500M--
Mar 3, 20252024/Q4194.700M / 254.667M--
Nov 6, 20242024/Q3293.800M / 297.500M--
Aug 6, 20242024/Q2254.700M / 190.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 194.000M--
--2025/Q1-- / 218.500M--
Mar 3, 20252024/Q4194.700M / 254.667M--
Nov 6, 20242024/Q3293.800M / 297.500M--
Aug 6, 20242024/Q2254.700M / 190.000M--

Unlock Free Earnings Estimates

Emergent BioSolutions Earnings Reports

Read more

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More